Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

The search for a cure news

Show

From To
This Small Anti-Viral Pill Might Lead to an HIV Cure

For the first time, scientists have shown it’s possible to reduce HIV reservoirs in people living with HIV, thanks to a tiny anti-viral molecule (ABX464) patented by the biotechnology company Abivax.

Published
11 May 2017
From
HIVPlusMag
CRISPR Eliminates HIV in Live Animals

New data released from a research team led by investigators at the Lewis Katz School of Medicine at Temple University (LKSOM) and the University of Pittsburgh shows that HIV DNA can be excised from the genomes of living animals to eliminate further infection. Additionally, the researchers are the first to perform this feat in three different animal models, including a "humanized" model in which mice were transplanted with human immune cells and infected with the virus

Published
02 May 2017
From
Genetic Engineering & Biotechnology News
Defective HIV proviruses hinder immune system response and cure

HIV proviruses can outnumber functional HIV 1000 copies to one and the faulty proteins they create can complicate efforts to measure a patient's viral load, exhaust immune systems, shield functional HIV from attack by natural means or drugs, and seriously complicate the development of a cure.

Published
19 April 2017
From
Science Daily
Biomarker Opens New Door in HIV Cure Research

For the first time, investigators have found a biomarker that identifies some cells latently infected with HIV.

Published
14 April 2017
From
MedPage Today HIV/AIDS
We asked a scientist to explain CRISPR to us—and how it’s being used in HIV research

Perhaps you’ve heard about a research technology called CRISPR (pronounced “crisper”) in the news. Since the technology was first developed, it has generated headlines as thousands of researchers have adopted this technology as a way to edit the genes of plant, animal and human cells.

Published
12 April 2017
From
BETA blog
Research helps explain how vedolizumab antibody therapy leads to sustained viral remission

HIV and its monkey cousin SIV can carry the alpha-4 beta-7 integrin receptor in their outer envelope, which helps the virus enter gut cells during early infection,

Published
23 March 2017
By
Liz Highleyman
Hidden HIV reservoirs exposed by telltale protein

The discovery helps to identify dormant infected cells and could one day lead to a cure.

Published
21 March 2017
From
Nature
Monkeys suppress HIV-like virus for extended period after dual-antibody treatment

Giving monkeys two powerful anti-HIV antibodies immediately after infection with an HIV-like virus enabled the immune systems of some of the animals to control the virus long after the antibodies were gone, scientists at the National Institutes of Health and The Rockefeller University have found.

Published
14 March 2017
From
Eurekalert Inf Dis
Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound

An HIV-positive bone marrow transplant recipient at the Mayo Clinic experienced prolonged viral remission lasting nearly 10 months – longer than the so-called Boston patients – after interrupting

Published
06 March 2017
By
Liz Highleyman
How to Keep HIV Cure-Related Trials Ethical: The Benefit/Risk Ratio Challenge

While high or unknown risks are a mainstay of early-phase trials in areas like cancer research, cure study participants typically have a safe and efficacious alternative to those risks: remaining on antiretrovirals. Can we justify asking patients who are doing well on antiretrovirals to accept the risk and uncertainty of many HIV cure-related trials? If we cannot, we might need to give up on the hope of curing HIV, or of achieving controlled remission.

Published
22 February 2017
From
BMJ Blogs
← First12345...42Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.